Evidence map›Paper›PMID 41532771›Full record

ArticleAntimicrobial agents and chemotherapy2026

Protective mechanism of action of the antifungal drug naftifine against

Jia Wang, Ruchi Paroha, Jian Sha, Atul K Verma, Blake H Neil, Paul B Kilgore, Emily K Hendrix, Barbara Brown-Elliott, Ashok K Chopra, Sunhee Lee

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jia WangDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0001-6125-3544
Ruchi ParohaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Jian ShaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Atul K VermaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Blake H NeilDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Paul B KilgoreDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Emily K HendrixDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Barbara Brown-ElliottMycobacteria/Nocardia Laboratory, The University of Texas Health Science Center at Tyler, The University of Texas at Tyler School of Medicine, Tyler, Texas, USA.
Ashok K ChopraDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0002-5223-3012
Sunhee LeeDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID 0000-0002-2599-6938

Funding

Project 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogenP01AI152999 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SAVIDGE, TOR C. · 2020 to 2025
$12.0M
POR Program on Genomic Prediction of Antimicrobial Resistance in VREK24AI121296 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2016 to 2025
$1.5M
Antimicrobial Resistance Training Program in the Texas Medical Center (AMR-TPT)T32AI179595 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI Cesar Augusto Arias · 2024 to 2026
$1.0M
FDA approved non-antibiotic drugs to combat multiple drug resistant microbesR56AI132682 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHOPRA, ASHOK K, DANN, SARA M · 2018 to 2018
$583k
National Institute of Allergy and Infectious Diseases R01 AI27711NIAID NIH HHS K24 AI121296NIAID NIH HHS P01 AI152999NIAID NIH HHS R56 AI132682NIAID NIH HHS T32 AI179595
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllylamineAnti-Bacterial AgentsAntifungal AgentsMycobacterium abscessusMycobacterium Infections, NontuberculousAnimalsAutophagyBacterial ProteinsDrug Resistance, Multiple, BacterialHumansMacrophagesMicrobial Sensitivity TestsTHP-1 CellsAllylamineAnti-Bacterial AgentsAntifungal AgentsBacterial ProteinsnaftifineFDA-approved drugsMmpL3Mycobacterium abscessusnaftifine

Identifiers

PMID41532771
PMCPMC12888883

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.